Login / Signup

Mutant KRAS inhibitors enter the scene of precision therapeutics for pancreatic cancer.

Gareth PollinGwen L LomberkAngela Joy MathisonMichael T ZimmermannRaul A Urrutia
Published in: Journal of gastrointestinal oncology (2024)
Keyphrases
  • wild type
  • small molecule